NO951163L - Metode for antagonisering av inositol-1,4,5-trifosfat - Google Patents

Metode for antagonisering av inositol-1,4,5-trifosfat

Info

Publication number
NO951163L
NO951163L NO951163A NO951163A NO951163L NO 951163 L NO951163 L NO 951163L NO 951163 A NO951163 A NO 951163A NO 951163 A NO951163 A NO 951163A NO 951163 L NO951163 L NO 951163L
Authority
NO
Norway
Prior art keywords
antagonizing
inositol
triphosphate
oligomers
oligomer
Prior art date
Application number
NO951163A
Other languages
English (en)
Norwegian (no)
Other versions
NO951163D0 (no
Inventor
Kenneth A Stauderman
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO951163L publication Critical patent/NO951163L/no
Publication of NO951163D0 publication Critical patent/NO951163D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/795—Polymers containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO951163A 1992-09-28 1995-03-27 Metode for antagonisering av inositol-1,4,5-trifosfat NO951163D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95239392A 1992-09-28 1992-09-28
PCT/US1993/008168 WO1994007507A1 (en) 1992-09-28 1993-08-30 Method for antagonizing inositol 1,4,5-triphosphate

Publications (2)

Publication Number Publication Date
NO951163L true NO951163L (no) 1995-03-27
NO951163D0 NO951163D0 (no) 1995-03-27

Family

ID=25492868

Family Applications (1)

Application Number Title Priority Date Filing Date
NO951163A NO951163D0 (no) 1992-09-28 1995-03-27 Metode for antagonisering av inositol-1,4,5-trifosfat

Country Status (13)

Country Link
EP (1) EP0661982A1 (zh)
JP (1) JPH08502068A (zh)
KR (1) KR950703347A (zh)
AU (1) AU670962B2 (zh)
CA (1) CA2145681A1 (zh)
HU (1) HUT70192A (zh)
IL (1) IL107066A (zh)
MX (1) MX9305933A (zh)
NO (1) NO951163D0 (zh)
NZ (1) NZ256178A (zh)
TW (1) TW260663B (zh)
WO (1) WO1994007507A1 (zh)
ZA (1) ZA936978B (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996000586A2 (en) * 1994-06-30 1996-01-11 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Methods for treating cell proliferative disorders by modulating signal transduction
EP0809492A4 (en) 1995-02-17 2007-01-24 Smithkline Beecham Corp IL-8 RECEPTOR ANTAGONISTS
US5780483A (en) * 1995-02-17 1998-07-14 Smithkline Beecham Corporation IL-8 receptor antagonists
US6083920A (en) * 1995-12-21 2000-07-04 Ayurcore, Inc. Compositions for modulating intracellular inositol trisphosphate concentration
US6005008A (en) * 1996-02-16 1999-12-21 Smithkline Beecham Corporation IL-8 receptor antagonists
US6211373B1 (en) 1996-03-20 2001-04-03 Smithkline Beecham Corporation Phenyl urea antagonists of the IL-8 receptor
US6262113B1 (en) 1996-03-20 2001-07-17 Smithkline Beecham Corporation IL-8 receptor antagonists
IL127666A0 (en) * 1996-06-27 1999-10-28 Smithkline Beecham Corp IL-8 receptor antagonists
HUP9903922A3 (en) 1996-06-27 2001-12-28 Smithkline Beecham Corp Il-8 receptor antagonists
EP1331932B1 (en) * 2000-11-09 2007-04-04 Contrimmune Biotechnology Inc. Use of xestospongin c for treating or preventing hiv infection
AU2012301617A1 (en) 2011-09-02 2014-04-17 Salk Institute For Biological Studies CaMKII, IP3R, calcineurin, p38 and MK2/3 inhibitors to treat metabolic disturbances of obesity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB781479A (en) * 1953-08-27 1957-08-21 Ciba Ltd New polyureas and process for making them
US5276182A (en) * 1990-07-09 1994-01-04 The Dow Chemical Company Process for preparing polyurea oligomers

Also Published As

Publication number Publication date
HU9500891D0 (en) 1995-05-29
EP0661982A1 (en) 1995-07-12
KR950703347A (ko) 1995-09-20
JPH08502068A (ja) 1996-03-05
NZ256178A (en) 1997-03-24
TW260663B (zh) 1995-10-21
MX9305933A (es) 1994-04-29
WO1994007507A1 (en) 1994-04-14
CA2145681A1 (en) 1994-04-14
ZA936978B (en) 1994-04-18
IL107066A (en) 1998-01-04
NO951163D0 (no) 1995-03-27
AU4841793A (en) 1994-04-26
IL107066A0 (en) 1993-12-28
AU670962B2 (en) 1996-08-08
HUT70192A (en) 1995-09-28

Similar Documents

Publication Publication Date Title
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
AU1876788A (en) Methylene phosphonoalkylphosphinates, pharmaceutical compositions , and methods for treating abnormal calcium and phosphate metabolism
UA27911C2 (uk) Засіб для лікування або запобігання фізіологічних розладів, які викликані надлишком тахікініну
NO951163L (no) Metode for antagonisering av inositol-1,4,5-trifosfat
HU912359D0 (en) The use of flupirtine active agents for treating muscle-tension
EP0363415A4 (en) Compounds for the treatment of alzheimer's disease
DE69716810D1 (de) 2,3-Disubstituierte-(5,6)-heteroarylkondensierte-pyrimidin-4-one
NO952890L (no) Kombinasjonsbehandling for inhibisjon av bentap
GR3023457T3 (en) Inhibitors of hiv protease useful for the treatment of aids.
NO902800L (no) Fremgangsmaate for fremstilling av 11beta-aryl-4-oestrener.
TW279162B (zh)
UA35584C2 (uk) Лікарський засіб для лікування або профілактики ішемії міокарда та спосіб лікування ішемії міокарда у ссавців
NO954896D0 (no) Aromatiske acetylcholinesteraseinhibitorer
ATE129156T1 (de) Verwendung von sulfatierten oligosacchariden zur behandlung arteriosklerotischer erkrankungen und zur verhinderung der restenosierung.
FI102896B1 (fi) Menetelmä farmaseuttisesti aktiivisen, rikkiä sisältävän heterosyklisen yhdisteen valmistamiseksi
ZA887399B (en) 4-aminopyridine derivatives
TW325997B (en) Pharmaceutical composition for preventing and treating retinal diseases
IL88740A0 (en) Compositions for the inhibition of viruses
HUT70757A (en) Pharmaceutical compositions for treating skin disorders
EP0305181A3 (en) Ethyl-(+)-apovincaminate for treating demyelinization clinical patterns of autoimmune origin
GR3034161T3 (en) Pharmaceutical composition for preventing or treating.
ATE88634T1 (de) Arzneimittel zur behandlung von herzinsuffizienz.
NO911237D0 (no) Fremgangsmaate for fremstilling av hydroxymethyl-indolizidiner og -kinolizidiner.
ATE113843T1 (de) Verwendung eines prolylendopeptidase-inhibitors zur behandlung von aids.
HUT49849A (en) Process for producing ketenedithioacetal derivatives and pharmaceutical compositions comprising these compounds as active ingredient